Dr. Podaralla Ramakrishna

Dr. Podaralla Ramakrishna
Psychiatrist, Hyderabad

MBBS, MD

  • 1 Hospital

Specialities

  • Psychiatry

Expertise

Education

  • MBBS, MD
  • Trained in “Community Psychiatry Program” at National Institute of Mental Health and Neurosciences, Bangalore, in 1983.
  • Attended W.H.O. workshop on “Community Psychiatry Program” at National Institute of Mental Health and Neurosciences, Bangalore.
  • Attended W.H.O. workshop on “Drug De-addiction program” at Hyderabad, in 1987.
  • Trained in “Drug and Alcohol dependence” at All India Institute of Medical Sciences, New Delhi, in 1989.
 

Practice Information

Owaisi Hospital And Research Centre, Hyderabad

Owaisi Hospital And Research Centre, Hyderabad

P.O. Kanchanbagh, DMRL ‘X’ Road, Santosh Nagar, Hyderabad, Telangana - 500058

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Podaralla Ramakrishna and his staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • Scientific papers (Publications):“Controlled study of the use of Relaxation Technique in the treatment of Essential Hypertension in O.P.D. setting”.  (M.D. Thesis, I.M.S., B.H.U., Varanasi)
  • “CAPGRAS syndrome – a case study” – published in Andhra Pradesh Journal of Psychological Medicine. (Read at South Zone Conference, I.P.S., Trivandrum, 1982)
  • “A study of criminal cases admitted in Mental Hospital” – paper presented at 15th Annual Conference of I.P.S. south Zone 1982.
  • “Psychiatric morbidity in rural Mental Health Clinics in A.P., India” –Paper presented at 15th regional Conference of I.P.S. South Zone 1982.
  • “A socio-demographic study of depression” –Paper presented at 15th regional Conference of I.P.S. South Zone 1982.
  • “Role of Multipurpose Health Workers in Mental Health Program – implications for NMHP of India”  (38th Annual Conference of I.P.S., Jaipur, 1986)
  • “Do anti-parkinsonism drugs have prophylactic value?”(Indian Journal of Psychiatry, 1983)
  • “A study of the use of relaxation technique in the treatment of essential hypertension”.   (Indian Journal of Physiological Medicine, July 1988)
  • “Bhanamati – a spectrum of crisis” - paper presented at II International Conference on recent advances in ‘Crisis intervention and community Mental Health’ held at Hyderabad in 1992.
  • “Efficacy of ECT versus carbamezapine therapy in Acute Manic  Episode” (1992)
  • “Effect of lunar phase on incidence of mental illness” (1992)
  • “Psychiatric aspects of HIV / AIDS and psychological management of AIDS patients. 
  • Paper presented at International Conference of HIV /AIDS, Mumbai, December 2001.
  • Organized CME programme on “Cognitive Behavior Therapy” at Deccan College of Medical Sciences, Hyderabad, on 19th Feb. 2006
  • Organized CME programme on “Genesis and Management of Schizophrenia” at Deccan College of Medical Sciences, Hyderabad, on 1st October 2006
  • Organized CME programme on “Recent Advances in Bipolar Disorders” at Deccan College of Medical Sciences, Hyderabad on 25th February 2007
  • Organized CME Programme on “ An Update on Anxiety Disorders” at Deccan College of Medical Sciences, Hyderabad on 2nd March 2008
  • Organized CME Programme on “ Personality Disorders-an update” at Deccan College of Medical Sciences, Hyderabad, on 1st March 2009
  • Organized a State Level Psychiatry Conference “APPSYCON” at Hyderabad on 27th and 28th June 2009
  • Organized CME Programme on “ Psychopharmacology- An Update” at Deccan College of Medical Sciences, Hyderabad, on 11th April 2010.Drug Trials:- Principal Investigator
  • “ A Phase IV randomized, double blind, Placebo and Active –Controlled , Parallel group study to evaluate the efficacy and safety of fixed dose of 1.5mg per day of Paliperidone Extended Release (ER) in the treatment of subjects with Schizophrenia” (Protocol R076477-SCH-4012)
  • R076477-3004- A Randomized, Double blind, active and placebo controlled, Parallel group, Multicenter Study to evaluate the efficacy and safety of Extended Release Paliperidone as mainstream treatment after an acute manic or mixed episode associated with Bipolar I Disorder.